We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.49B
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
-0.72%
1 Year Est. Return
+30.44%
3 Year Est. Return
+88.59%
5 Year Est. Return
+121.06%
10 Year Est. Return
+327.09%
AUM
$6.57B
AUM Growth
+$83.2M
Cap. Flow
+$171M
Cap. Flow %
2.61%
Top 10 Hldgs %
34.7%
Holding
396
New
51
Increased
77
Reduced
121
Closed
60

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$120M
2
AMAT icon
Applied Materials
AMAT
+$102M
3
JPM icon
JPMorgan Chase
JPM
+$91.6M
4
PHG icon
Philips
PHG
+$84.9M
5
PF
Pinnacle Foods, Inc.
PF
+$72.7M

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$131M
2
MRK icon
Merck
MRK
+$126M
3
CMCSA icon
Comcast
CMCSA
+$104M
4
QCOM icon
Qualcomm
QCOM
+$77.7M
5
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$60.4M

Sector Composition

Rank Sector Weight
1 Healthcare 17.56%
2 Financials 16.11%
3 Technology 13.74%
4 Industrials 11.22%
5 Energy 10.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TT icon
176
Trane Technologies
TT
$93B
$1.77M 0.03%
31,431
-2,063
-6% -$125K
WY icon
177
Weyerhaeuser
WY
$16.1B
$1.77M 0.03%
55,600
– –
DBRG icon
178
DigitalBridge
DBRG
$2.97B
$1.75M 0.03%
+23,750
New +$1.79M
SEMG
179
DELISTED
SEMGROUP CORPORATION
SEMG
$1.72M 0.03%
20,700
-3,212
-13% -$265K
GLF
180
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$1.68M 0.03%
53,450
– –
UHS icon
181
Universal Health Services
UHS
$10.4B
$1.67M 0.03%
16,000
– –
RVNC
182
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.6M 0.02%
82,655
-102,111
-55% -$2.66M
TWTC
183
DELISTED
TW TELECOM INC CL A COM
TWTC
$1.58M 0.02%
+38,037
New +$1.55M
BX icon
184
Blackstone
BX
$95.1B
$1.57M 0.02%
50,937
-6,305
-11% -$205K
CNA icon
185
CNA Financial
CNA
$13.1B
$1.57M 0.02%
41,250
– –
LOW icon
186
Lowe's Companies
LOW
$109B
$1.55M 0.02%
29,378
– –
ENDP
187
DELISTED
Endo International plc
ENDP
$1.49M 0.02%
21,762
-303
-1% -$20K
TYC
188
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$1.47M 0.02%
31,379
-2,157
-6% -$100K
KND
189
DELISTED
Kindred Healthcare
KND
$1.43M 0.02%
73,828
+6,572
+10% +$143K
GXP
190
DELISTED
Great Plains Energy Incorporated
GXP
$1.43M 0.02%
59,241
-40,184
-40% -$1.02M
PNR icon
191
Pentair
PNR
$9.03B
$1.42M 0.02%
32,274
+7,560
+31% +$350K
BMY icon
192
Bristol-Myers Squibb
BMY
$130B
$1.39M 0.02%
27,080
– –
DHR icon
193
Danaher
DHR
$147B
$1.38M 0.02%
26,946
-3,166
-11% -$163K
TTEK icon
194
Tetra Tech
TTEK
$9.4B
$1.37M 0.02%
275,000
– –
ES icon
195
Eversource Energy
ES
$25.3B
$1.33M 0.02%
29,998
-6,895
-19% -$310K
DUK icon
196
Duke Energy
DUK
$91.8B
$1.3M 0.02%
17,433
-6,783
-28% -$495K
TIF
197
DELISTED
Tiffany & Co.
TIF
$1.3M 0.02%
13,530
-4,777
-26% -$476K
D icon
198
Dominion Energy
D
$56.2B
$1.3M 0.02%
+18,820
New +$1.3M
CMS icon
199
CMS Energy
CMS
$20.7B
$1.29M 0.02%
43,596
-9,275
-18% -$277K
EAT icon
200
Brinker International
EAT
$8.5B
$1.27M 0.02%
+25,042
New +$1.2M
6 7
8
9 10

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.49B AUM 32.81% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $1.49B AUM 26.43% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.49B AUM 28.35% 1-Year Est. Return
PMG
ProVise Management Group Clearwater, Florida $1.49B AUM 21.79% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
TIA
Tandem Investment Advisors Charleston, South Carolina $1.49B AUM 12.33% 1-Year Est. Return
MM
Main Management San Francisco, California $1.49B AUM 22.28% 1-Year Est. Return
WA
WBH Advisory Baltimore, Maryland $1.49B AUM 20.41% 1-Year Est. Return

Levin Capital Strategies's Q3 2014 Portfolio in Review

As of Q3 2014, Levin Capital Strategies held 396 positions worth $6.57B, up 1.3% from $6.49B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Levin Capital Strategies's Q3 2014 filing shows 51 new, 77 increased, 121 reduced and 60 closed positions. Its largest new stake was Applied Materials: 4,606,467 shares worth $99.5M. The largest sale was Wells Fargo, an estimated $131M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

  • Levin Capital Strategies's largest Q3 2014 buy was Applied Materials: 4,606,467 shares worth $99.5M.
  • Levin Capital Strategies added most to Allergan plc in Q3 2014, an estimated $120M increase.
  • Levin Capital Strategies's biggest Q3 2014 reduction was Merck, cutting an estimated $126M.
  • Levin Capital Strategies fully exited Wells Fargo in Q3 2014, selling an estimated $131M.
  • Levin Capital Strategies's ten largest holdings make up 35% of its $6.57B portfolio in Q3 2014.
  • Levin Capital Strategies opened 51 new positions and closed 60 in Q3 2014.
  • Levin Capital Strategies's portfolio value rose 1.3% quarter-over-quarter to $6.57B.

Based on Levin Capital Strategies's 13F filing for Q3 2014, filed 12 Nov 2014.